Think Investments’s Organon & Co OGN Stock Holding History

Think Investments’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,000,000	Closed	-$24M	–	34
2026 Q1	$24M	Buy	+4,000,000	New	+$30.1M	3.14%	14

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Think Investments's OGN Position: Q2 2026 in Review

Think Investments sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 4,000,000 shares — an estimated $24M sold.

Think Investments first reported a position in OGN in Q1 2026 and held it in 1 quarter. The position peaked at $24M in Q1 2026. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Think Investments reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Think Investments sold 4,000,000 Organon & Co shares in Q2 2026, an estimated $24M.
Think Investments first reported a position in Organon & Co in Q1 2026 and held it in 1 quarter.
Think Investments's Organon & Co position peaked at $24M in Q1 2026.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Think Investments's 13F filing for Q2 2026, filed 14 Aug 2026.